Year All20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998 BioCryst Celebrates Bob Ingram’s Contributions to the Company’s Success Mar 29, 2023 Read More BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Mar 02, 2023 Read More BioCryst Presents New Long-term and Real-world Data Demonstrating Sustained Reductions in Hereditary Angioedema Attack Rates and Improvement in Quality of Life with ORLADEYO® (berotralstat) Feb 24, 2023 Read More BioCryst to Present at Upcoming Investor Conferences Feb 22, 2023 Read More BioCryst Reports Fourth Quarter and Full Year 2022 Financial Results and Upcoming Key Milestones Feb 21, 2023 Read More BioCryst to Report Fourth Quarter 2022 Financial Results on February 21 Feb 07, 2023 Read More BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Feb 06, 2023 Read More BioCryst to Present New ORLADEYO® (berotralstat) Data at 2023 American Academy of Allergy, Asthma & Immunology Annual Meeting Feb 03, 2023 Read More BioCryst Begins Enrollment in Pivotal APeX-P Trial Evaluating ORLADEYO® (berotralstat) in Pediatric Patients with Hereditary Angioedema Jan 26, 2023 Read More BioCryst Selects Swixx BioPharma as Commercial Partner for ORLADEYO® (berotralstat) in Central and Eastern Europe Jan 23, 2023 Read More
BioCryst Presents New Long-term and Real-world Data Demonstrating Sustained Reductions in Hereditary Angioedema Attack Rates and Improvement in Quality of Life with ORLADEYO® (berotralstat) Feb 24, 2023 Read More
BioCryst Reports Fourth Quarter and Full Year 2022 Financial Results and Upcoming Key Milestones Feb 21, 2023 Read More
BioCryst to Present New ORLADEYO® (berotralstat) Data at 2023 American Academy of Allergy, Asthma & Immunology Annual Meeting Feb 03, 2023 Read More
BioCryst Begins Enrollment in Pivotal APeX-P Trial Evaluating ORLADEYO® (berotralstat) in Pediatric Patients with Hereditary Angioedema Jan 26, 2023 Read More
BioCryst Selects Swixx BioPharma as Commercial Partner for ORLADEYO® (berotralstat) in Central and Eastern Europe Jan 23, 2023 Read More